0.36
+0.0056(+1.60%)
Currency In USD
| Previous Close | 0.35 |
| Open | 0.39 |
| Day High | 0.39 |
| Day Low | 0.35 |
| 52-Week High | 3.22 |
| 52-Week Low | 0.22 |
| Volume | 967,086 |
| Average Volume | 2.32M |
| Market Cap | 14.78M |
| PE | -0.16 |
| EPS | -2.23 |
| Moving Average 50 Days | 0.37 |
| Moving Average 200 Days | 0.65 |
| Change | 0.01 |
If you invested $1000 in ProPhase Labs, Inc. (PRPH) 10 years ago, it would be worth $223.84 as of July 31, 2025 at a share price of $0.356. Whereas If you bought $1000 worth of ProPhase Labs, Inc. (PRPH) shares 5 years ago, it would be worth $118.63 as of July 31, 2025 at a share price of $0.356.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement
GlobeNewswire Inc.
Jul 29, 2025 12:00 PM GMT
Proxy Sets Company on a Path to Attract the Optimal Crypto Treasury Strategy Increase in Authorized Shares to 1 Billion Would Position the Company to Attract Industry-Leading Market Participants and High-Value Crypto Treasury Transactions UNIONDALE,
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing
GlobeNewswire Inc.
Jul 23, 2025 12:00 PM GMT
Financing provides bridge to multiple potentially significant liquidity events and crypto strategies UNIONDALE, NY, July 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the "Company" or "ProPhase") today announced the closing of a
ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative
GlobeNewswire Inc.
Jul 21, 2025 12:00 PM GMT
UNIONDALE, NY, July 21, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced that its Board of Directors has unanimously author